State VA
Clinical Trials in Virginia
Recruiting clinical trials with at least one study location in Virginia. Data updated daily from ClinicalTrials.gov.
Top Conditions in Virginia
NCT06959524 N/A
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Co...
Condition
Coronary Arterial Disease (CAD)
Enrollment
1,616 pts
Location
United States, Australia, Germany
Sponsor
Boston Scientific Corporation
NCT04831580 N/A
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Condition
Cervical Cancer
Enrollment
840 pts
Location
United States, Canada
Sponsor
GOG Foundation
NCT03325946 N/A
Recruiting
The FBRI VTC Neuromotor Research Clinic
Condition
Neuromotor Impairments
Enrollment
500 pts
Location
United States
Sponsor
Virginia Polytechnic Institute
NCT06481891 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obst...
Condition
Obstructive Cardiomyopathy, Hypertrophic
Enrollment
500 pts
Location
United States, Argentina, Belgium
Sponsor
Lexicon Pharmaceuticals
NCT05230459 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With...
Condition
Limb Girdle Muscular Dystrophy
Enrollment
10 pts
Location
United States
Sponsor
AskBio Inc
NCT06237179 Phase 1, Phase 2
Recruiting
Behavioral Exercise Training to Reduce Cardiovascular Disease Risk
Condition
Prostate Cancer
Enrollment
60 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
NCT06794996 Phase 2
Recruiting
Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or...
Condition
Proteinuric Kidney Disease
Enrollment
45 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06095583 Phase 3
Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consol...
Condition
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Enrollment
756 pts
Location
United States, Belgium, China
Sponsor
Shanghai Junshi Bioscience Co.
NCT06091254 Phase 3
Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Work...
Condition
Follicular Lymphoma (FL)
Enrollment
822 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
NCT05006482 Phase 3
Recruiting
Geriatric Evaluation and Management With Survivorship Health Education for Older...
Condition
Lymphoma
Enrollment
668 pts
Location
United States
Sponsor
University of Rochester
NCT06395753 Phase 2
Recruiting
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Condition
Prostate Cancer
Enrollment
66 pts
Location
United States, Belgium, France
Sponsor
Debiopharm International SA
NCT06029660 N/A
Recruiting
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of...
Condition
Aortic Aneurysm, Abdominal
Enrollment
180 pts
Location
United States, France, Netherlands
Sponsor
Shape Memory Medical, Inc.
NCT07222020 Phase 1
Recruiting
Phase 1 Study of Intravaginal KB15A
Condition
Healthy Subjects
Enrollment
24 pts
Location
United States
Sponsor
ZabBio Inc.
NCT03785288 Phase 3
Recruiting
Vaginal Cuff Brachytherapy Fractionation Study
Condition
Endometrial Cancer
Enrollment
258 pts
Location
United States
Sponsor
Kara Romano, MD
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT05004129 Phase 2, Phase 3
Recruiting
Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dyst...
Condition
Congenital Myotonic Dystrophy
Enrollment
76 pts
Location
United States, Australia, Canada
Sponsor
AMO Pharma Limited
NCT06774131 Phase 3
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract...
Condition
Upper Urinary Tract Urothelial Carcinoma
Enrollment
70 pts
Location
United States, Bulgaria, Georgia
Sponsor
UroGen Pharma Ltd.
NCT06072482 Phase 4
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Condition
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Enrollment
300 pts
Location
United States, Czechia, Hungary
Sponsor
Amgen
NCT00969111 N/A
Recruiting
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Fol...
Condition
Prostate Cancer
Enrollment
70 pts
Location
United States
Sponsor
Proton Collaborative Group
NCT06861309 N/A
Recruiting
Placental Imaging Techniques
Condition
Fetal Growth Restriction (FGR)
Enrollment
60 pts
Location
United States
Sponsor
Carilion Clinic
NCT06356571 Phase 2
Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfil...
Condition
Plasma Cell Myeloma Refractory
Enrollment
64 pts
Location
United States
Sponsor
Sanofi
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals
NCT03298334 Phase 1, Phase 2
Recruiting
Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.
Condition
Cesarean Delivery Affecting Newborn
Enrollment
600 pts
Location
United States
Sponsor
National Institute of Allergy
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen